Oxy-cope rearrangement for the manufacture of insecticidal cyclopentene compounds

US10526264B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10526264-B2
Application numberUS-201716315417-A
CountryUS
Kind codeB2
Filing dateJun 23, 2017
Priority dateJul 7, 2016
Publication dateJan 7, 2020
Grant dateJan 7, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds of formula I a process for preparation of compounds of formula I; precursor compounds of formula II a process for preparation of precursor compounds of formula II; compounds of formula III a process for the preparation of compounds of formula IV from compounds of formula III and the use of compounds of formula I for the preparation of compounds of formula IV.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula I wherein R 1 is halomethyl; R 2 is halogen, halomethyl, or halomethoxy; R 3 , R 4 are independently H, or as defined for R 2 ; R 5a is H, C 1 -C 4 -alkyl, or C 1 -C 4 -haloalkyl; R 5b is CN, halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, C 1 -C 2 -alkoxy, C 1 -C 2 -haloalkoxy; or R 5a and R 5b form together with the C-atoms they are bound to a 5-, or 6-membered saturated, partially, or fully unsaturated ring containing none, or one heteroatom O, N(O) n or S(O) m as ring members; A is halogen, CN, C 1 -C 6 -alkoxy, C 6 -C 10 -aryloxy, C 1 -C 6 -haloalkoxy, C 6 -C 10 -arylalkoxy, C 6 -C 10 -aryl-C 1 -C 6 -alkoxy, OS(O) 2 R 6 ; or a group A 1 , or A 2 ; wherein A 1 is a group of following formula: wherein # denotes the attachment point to the remainder of the molecule; Y OR 7 , or N(R 8 )R 9 ; and A 2 is a group of following formula: wherein # denotes the attachment point to the remainder of the molecule; R 6 halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl; phenyl, which is unsubstituted, or substituted by halogen, OH, CN, NO 2 , C 1 -C 6 -alkyl, or C 1 -C 6 -haloalkyl; R 7 a) H; b) C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkenyl, C 1 -C 6 -alkynyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl; or c) phenyl, or benzyl, which are unsubstituted, or substituted by halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, or C 1 -C 2 -alkoxy; R 8 H, CN; C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); C 1 -C 10 -alkyl, C 3 -C 8 -cycloalkyl, C 2 -C 10 -alkenyl, C 2 -C 10 -alkynyl, which are unsubstituted or substituted by R 81 ; R 81 halogen, CN, N 3 , NO 2 , SCN, SF 5 , C 3 -C 8 -cycloalkyl, C 3 -C 8 halocycloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 3 -C 8 -cycloalkoxy, or C 3 -C 8 -halocycloalkoxy; R 9 H; C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; N(R 93 )R 94 ; phenyl, heterocyclyl, or hetaryl, which are unsubstituted, or substituted by R D ; or C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); R 91 halogen, OH, CN, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkyl-S(O) m , C 1 -C 4 -haloalkyl-S(O) m , C(═O)N(R A )R B ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R C ; phenyl, heterocyclyl, or hetaryl which are unsubstituted, or substituted by R D ; R A , R 93 H, C 1 -C 3 -alkyl, or C 1 -C 3 -haloalkyl; R B H, C 1 -C 3 -alkyl, C 1 -C 3 -haloalkyl, C 2 -C 3 -alkenyl, C 2 -C 3 -haloalkenyl, C 2 -C 3 -alkynyl, C 2 -C 3 -haloalkynyl, C 1 -C 3 -alkoxy, C 1 -C 3 -haloalkoxy, C 3 -C 4 -halocycloalkyl; or C 3 -C 4 -cycloalkyl, C 3 -C 4 -halocycloalkyl, C 3 -C 4 -cycloalkylmethyl, C 3 -C 4 -halocycloalkylmethyl, wherein the cyclic groups are unsubstituted, or substituted by CN; R C OH, CN, C 1 -C 2 -alkyl, or C 1 -C 2 -haloalkyl; R D halogen, CN, NO 2 , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -haloalkenyl, C 2 -C 4 -alkynyl, C 2 -C 4 -haloalkynyl, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, C 3 -C 4 -cycloalkylmethyl, or C 3 -C 4 -halocycloalkylmethyl; or two R D present on the same carbon atom of a saturated, or partially saturated ring form together a carbonyl group (═O); R 92 C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, or a group as defined for R 91 ; R 94 C(═O)N(R A )R B , C(═O)OR A ; or phenyl, heterocyclyl, or hetaryl which rings are unsubstituted, or substituted by R D ; R 10 H, CN, methyl, or halomethyl; R 11 H, C 1 -C 6 -alkyl-C(═O), C 1 -C 6 -haloalkyl-C(═O), C 1 -C 6 -alkyl-OC(═O), C 1 -C 6 -alkenyl-OC(═O), or C 6 -C 12 -aryl-C 1 -C 6 -alkyl-OC(═O); R 12 H, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; or phenyl, heterocycyl, or hetaryl which rings are unsubstituted, or substituted by R D ; n is 0, or 1; m is 0, 1, or 2; and the N-oxides, stereoisomers and agriculturally or veterinarily acceptable salts thereof. 2. The compound of claim 1 , wherein R 1 is CF 3 ; R 2 is F, Cl, Br, CF 3 , or OCF 3 ; R 3 , R 4 are independently H, or as defined for R 2 ; R 5a is H; and R 5b is F, Cl, Br, CH 3 , or CF 3 ; or R 5a and R 5b form together with the C-atoms they are bound to a bridging group selected from —CH═CH—CH═CH—, —CH═CH—CH═N—, —CH═CH—N═CH—, —CH═N—CH═CH—, —N═CH—CH═CH—, —CH 2 CH 2 CH 2 —, —CH 2 CH 2 CH 2 CH 2 —, —CH 2 CH 2 O—, —OCH 2 CH 2 —, —CH 2 CH 2 CH 2 O—, —OCH 2 CH 2 CH 2 —, —CH 2 CH 2 S(O) p —, —S(O) p CH 2 CH 2 —; and wherein p is 0, 1, or 2. 3. The compound of claim 1 , wherein A is A 1 ; Y is OR 7 ; and R 7 is as defined in claim 1 . 4. The compound of claim 3 , wherein R 7 is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkenyl, C 1 -C 6 -alkynyl, phenyl, or benzyl. 5. The compound of claim 2 , wherein A is A 1 ; Y is N(H)R 9 . 6. The compound of claim 1 , wherein A is Cl, Br, I, or CN. 7. The compound of claim 1 , wherein A is A 2 ; R 10 H; and R 12 C 1 -C 4 -alkyl, and C 1 -C 4 -haloalkyl, which are unsubstituted, or substituted by R 91 ; C 3 -C 5 -cycloalkyl, C 3 -C 5 -halocycloalkyl, which are unsubstituted, or substituted by R 92 ; R 91 is independently OH, CN, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkyl-S(O) m , C 1 -C 4 -haloalkyl-S(O) m ; C 3 -C 5 -cycloalkyl, C 3 -C 5 -halocycloalkyl, which are unsubstituted, or substituted by R C ; R C is independently OH, CN, C 1 -C 2 -alkyl, or C 1 -C 2 -haloalkyl; R 92 is independently C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, or a group as defined for R 91 ; and m is 0, 1, or 2. 8. A process for preparing the compound of claim 1 comprising reacting a compound of formula II with a base at a temperature from −100 to 50° C., followed by rearrangement at a temperature from −50 to 150° C. 9. The process of claim 8 , wherein the reaction of the compound of formula (II) with the base is carried out in a solvent selected from the selected from an aliphatic C 5 -C 16 -hydrocarbon, aromatic C 6 -C 10 -hydrocarbon, halogenated aliphatic C 1 -C 6 -hydrocarbon, halogenated aromatic C 6 -C 10 -hydrocarbon, a C 1 -C 6 -cycloalkyl ether, a C 1 -C 6 -alkyl-C 1 -C 6 -alkyl ether, and a C 1 -C 6 -alkyl-C 6 -C 10 -aryl ether, or a mixture thereof. 10. The process of claim 8 , wherein the rearrangement is carried out at a temperature from −10 to 40° C. 11. The process of claim 8 , wherein compound of formula I are subsequently reacted with an olefinating agent to compound of formula III wherein all substituents have

Assignees

Inventors

Classifications

  • by increase in the number of carbon atoms · CPC title

  • C07C33/486Primary

    Polycyclic · CPC title

  • Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring · CPC title

  • having unsaturation outside the aromatic rings · CPC title

  • polycyclic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10526264B2 cover?
Compounds of formula I a process for preparation of compounds of formula I; precursor compounds of formula II a process for preparation of precursor compounds of formula II; compounds of formula III a process for the preparation of compounds of formula IV from compounds of formula III …
Who is the assignee on this patent?
Basf Se
What technology area does this patent fall under?
Primary CPC classification C07C33/486. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).